Clinical trial
Perioperative Insulin Glargine Dosing Study
NCT00309465 · Tamra Dukatz, Other · Completed
Key facts
| NCT number | NCT00309465 |
|---|---|
| Title | Perioperative Insulin Glargine Dosing Study |
| Official title | A Study of the Relationship Between the Proportional Insulin Glargine Evening Dose and the Perioperative Serum Glucose Values in Patients With Diabetes Undergoing Surgery |
| Lead sponsor | Tamra Dukatz, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Surgery |
| Intervention type | Drug, Other |
| Interventions | Lantus, Insulin |
| Enrollment | 402 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | Mar 31, 2006 |
| Last update posted | Dec 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: